New findings from the UK Dementia Research Institute at University College London (UCL) indicate that immune cells in the gut play a critical role in the spread of Parkinson’s disease from the digestive system to the brain. This research, conducted on mice and published in the journal Nature, opens the door to potential therapeutic strategies aimed at intervening long before the onset of motor symptoms associated with the condition.
For years, scientists have suspected that Parkinson’s disease may originate in the gut, particularly since one of the earliest affected areas in the brain is the dorsal motor nucleus of the vagus nerve, which is directly linked to gut function. However, the mechanisms behind this transmission have remained unclear until now.
Key Findings of the Study
The study highlights the role of gut macrophages—specialized immune cells that serve as the body’s first line of defense. Researchers identified that these cells assist in the transport of toxic proteins from the gut to the brain. By reducing the number of gut macrophages in the experimental mice, scientists observed a decrease in the spread of toxic proteins and an improvement in motor symptoms.
This research is particularly relevant considering that previous studies indicate that between 50% and 90% of individuals with Parkinson’s experience gastrointestinal issues long before they develop movement-related symptoms. Symptoms such as chronic constipation can appear decades prior to a Parkinson’s diagnosis, emphasizing the significance of early detection and intervention.
In their investigation, the researchers isolated misfolded alpha-synuclein, the toxic protein linked to Parkinson’s, from the brains of deceased patients. They then introduced small amounts of this protein into the small intestines of mice, tracking its progression to the brain. The results demonstrated that gut macrophages not only engulfed the alpha-synuclein but also exhibited signs of dysfunction, particularly in their lysosomal systems that are tasked with breaking down cellular waste.
Implications for Future Research
As the macrophages reacted to the presence of alpha-synuclein, they signaled to T cells, which are integral to the body’s adaptive immune response. These “gut-instructed” T cells then migrated from the gut to the brain. Notably, when the researchers depleted gut macrophages prior to introducing alpha-synuclein, the resulting levels of toxic protein in the brain were significantly lower compared to control mice, suggesting a promising pathway for therapeutic intervention.
In the next phase of their research, the team plans to further explore how the immune system affects brain health in a negative manner and how this understanding might lead to new drug targets. They will also investigate the potential of using markers of inflammation in the blood as early diagnostic tools for Parkinson’s disease.
Co-lead author Dr. Soyon Hong, Group Leader at the UK Dementia Research Institute at UCL, noted, “Our study shows that immune cells are not bystanders in Parkinson’s; these gut macrophages are responding, albeit in a dysfunctional way. This presents an opportunity to think about how we can boost the function of the immune system and these cells, so that they respond in the correct manner and help to slow or stop the spread of disease.”
Another co-lead, Dr. Tim Bartels, emphasized the long-term implications of understanding the disease’s origin, stating, “Neurodegenerative diseases have slow trajectories over decades. Understanding how Parkinson’s begins in the body could allow us to develop simple blood tests to screen for it, enabling diagnosis long before damage to the brain starts. Detecting and managing Parkinson’s before it even reaches the brain could have a huge impact for those affected.”
This research represents a significant advancement in the understanding of Parkinson’s disease, paving the way for innovative approaches to treatment and early diagnosis that could alter the lives of millions worldwide.
